PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 70 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $61,296 | -70.5% | 19,837 | -59.7% | 0.00% | -75.0% |
| Q4 2022 | $208,082 | +383.9% | 49,192 | +169.1% | 0.00% | +300.0% |
| Q3 2022 | $43,000 | -85.5% | 18,283 | -82.5% | 0.00% | -87.5% |
| Q2 2022 | $297,000 | -52.9% | 104,223 | -52.4% | 0.01% | -52.9% |
| Q1 2022 | $630,000 | -48.6% | 218,917 | -45.7% | 0.02% | -55.3% |
| Q4 2021 | $1,225,000 | +402.0% | 403,119 | +1350.1% | 0.04% | +137.5% |
| Q4 2019 | $244,000 | -35.6% | 27,800 | -6.7% | 0.02% | -61.9% |
| Q2 2019 | $379,000 | +205.6% | 29,800 | +1001.3% | 0.04% | -27.6% |
| Q3 2018 | $124,000 | – | 2,706 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 207,500 | $21,609,000 | 4.97% |
| WEATHERBIE CAPITAL, LLC | 250,296 | $26,066,000 | 2.47% |
| Redmile Group, LLC | 172,092 | $17,922,000 | 2.14% |
| Tekla Capital Management LLC | 185,820 | $19,351,000 | 1.93% |
| Iguana Healthcare Management, LLC | 35,000 | $3,645,000 | 1.68% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $592,210,000 | 1.62% |
| Atika Capital Management LLC | 11,350 | $1,182,000 | 1.01% |
| Eventide Asset Management | 44,900 | $4,676,000 | 0.73% |
| Ghost Tree Capital, LLC | 11,330 | $1,180,000 | 0.70% |
| BB BIOTECH AG | 117,991 | $12,288,000 | 0.63% |